Our Recommendations
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- Manual de Biossegurança Laboratorial (2021)
- Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities (2021)
- Serology-based tests for COVID-19 (2020)
- Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases (2020)
New Publications
- Directrices de Laboratorio para la Detección y el Diagnóstico de la Infección con el coronavirus del Síndrome Respiratorio del Medio Oriente (MERS–CoV) (2022)
- Note d’orientation de l’OMS : tests de diagnostic de la COVID-19 (2022)
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- WHO policy brief: COVID-19 testing, 14 September 2022 (2022)
- Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (2022)
Filter
137
Featured
Recommendations
39
Language
Document type
Guidelines
81
Fact sheets
20
Manuals
10
Training Material
5
Studies & Reports
5
Online Courses
5
Videos
4
Resource Platforms
3
Infographics
3
No document type
1
Countries / Regions
Germany
14
Russia
11
East and Southern Africa
9
Africa
8
West and Central Africa
7
Brazil
7
Latin America and the Carribbean
6
Mozambique
4
Global
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Angola
4
Spain
2
South Africa
2
China
1
Kazakhstan
1
Guinea-Bissau
1
Western Pacific Region
1
Western and Central Europe
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
COVID-19
48
Guidelines
15
Virology
14
General Guidelines
5
Online Courses & Platforms
3
Information, Education and Communication (IEC)
2
Capacity Building
2
Online Courses Platforms
1
Bacteriology
1
x MEDBOX Issue Brief & Annual Reports x
1
Policies
1
Drugs & Medical Equipment
1
Parasitology
1
Laboratory Quality Assurance
1
Toolboxes
Los coronavirus son un grupo de virus ARN altamente diversos de la familia Coronaviridae que se dividen en
4 géneros: alfa, beta, gamma y delta, y que causan enfermedades de leves a graves en humanos y animales
(1-3). Existen coronavirus humanos endémicos como los alfacoronavirus 229E y NL63 y l...
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises.
It remains critical for national programmes to continue to offer testing for COVI...
Les notes d’orientation exposent les mesures essentielles que les décideurs peuvent mettre en œuvre aux niveaux national et infranational pour les éléments suivants : tests de diagnostic de la COVID-19, prise en charge clinique de la COVID-19, atteinte des cibles en matière de vaccination con...
To meet the need for laboratory diagnosis to be integrated in community care, the new 2022 Update describes point-of-care tests that can be performed both in district laboratories and peripheral healthcare facilities by non-specialist staff. Also included are recently developed self-tests.
Manual de Biossegurança Laboratorial
recommended
Quarta Edição.
Esta quarta edição do manual se baseia no esquema de avaliação de risco apresentado na terceira edição. Uma avaliação completa, baseada em evidências e transparente dos riscos permite que as medidas de segurança sejam equilibradas com o risco real de trabalhar com agentes...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
he Framework sets the requirements for facilities handling High Consequence Agents and Toxins (HCATs) and guides the implementation of laboratory biosafety and biosecurity practices associated with the design, commissioning, routine operation safe and secure biocontainment laboratories.
Revised COVID-19 Testing Strategy
recommended
Second edition. June 2022. This revised guidance recommends that access to COVID-19 testing is decentralized as far as possible and made available at health facilities, and through the use of self tests to enable access to care and the mitigation of transmission. Testing should be prioritized for hi...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
Весь персонал, проводящий экспресс-диагностику антигена SARS-CoV-2 (Ag-RDT), должен понимать, как безопасно проводить тестирование, обеспечивать качество тестирования и и...
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time a...
This guidance addresses rationale, risk-based scenarios, practical considerations prior to adoption of the self-testing products, quality assurance, safety and ethical considerations, and data management considerations for COVID-19 self-testing. The Africa CDC recommends the use of rapid antigen sel...
Über SARS-CoV-2-Testsysteme informieren das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) und das Paul-Ehrlich-Institut. Die Informationen ergänzen sich, den rechtlichen Rahmen bietet u.a. die Coronavirus-Testverordnung-TestV.
Das BfArM bietet eine Liste von Antigen-Tests zum dir...
Esta quarta edição do manual se baseia no esquema de avaliação de risco apresentado na terceira edição. Uma avaliação completa, baseada em evidências e transparente dos riscos permite que as medidas de segurança sejam equilibradas com o risco real de trabalhar com agentes biológicos, caso...
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
La détection directe des protéines virales du SRAS-CoV-2 (antigènes) dans les écouvillons nasaux et autres sécrétions respiratoires à l'aide de tests immunologiques à flux latéral (également appelés tests de diagnostic rapide, TDR) offre une méthode plus rapide et moins coûteuse pour te...
